R. J. Monroe

Advanced Cell Diagnostics (United States)

Papers

1

Total Citations

6

H-Index

1

About

R. J. Monroe is a molecular pathologist whose research focuses on the development and application of novel RNA-based diagnostic tools, with a particular emphasis on telomerase reverse transcriptase (TERT) expression in cancer. Monroe’s most significant contribution to the field is the pioneering work on the evaluation of TERT mRNA expression using RNAscope®, a highly sensitive in situ hybridization technique. In a landmark 2022 study, Monroe demonstrated that this method can serve as a powerful histopathologic diagnostic and prognostic tool, enabling precise visualization of TERT expression at the single-cell level in tissue samples. This work has garnered 6 citations, establishing Monroe as a key figure in bridging molecular biology with clinical pathology. By providing a reliable alternative to traditional TERT promoter mutation testing, Monroe’s research has opened new avenues for cancer diagnosis and patient stratification, particularly in tumors where TERT activation is a critical driver. Monroe’s innovative approach has the potential to transform routine pathology workflows, offering pathologists a more accessible and informative tool for assessing tumor aggressiveness and guiding treatment decisions.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Evaluation of TERT mRNA expression using RNAscope®: A potential histopathologic diagnostic and prognostic tool
6 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Advanced Cell Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago